Reading Your Full Hormone Panel
Beyond total testosterone, the numbers that change the picture
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (guidance)
Reference only. Not medical advice.
This is something to take to a clinician. The Atlas can tell you what is known about reading your full hormone panel in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
A meaningful evaluation is not a single total-testosterone number. The useful panel includes: total testosterone (morning, ideally LC-MS/MS), SHBG and calculated free testosterone (Vermeulen), LH and FSH (to localize the problem to testes vs pituitary), prolactin (to catch a prolactinoma), estradiol by sensitive assay if symptomatic, a CBC for baseline hematocrit, PSA if over 40, and metabolic/iron studies to catch reversible causes. Each value reframes the others: a normal total with high SHBG can still mean low free testosterone; high LH/FSH points to a testicular cause; high prolactin points upstream. Reading the panel as a whole prevents both false 'Low T' diagnoses and missed real ones.
Total testosterone alone can mislead, the full panel tells the real story.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
What people get wrong
Often saidTotal testosterone is the only number that matters
ActuallySHBG, free T, LH/FSH, prolactin, and estradiol each change the interpretation. Total T alone can both over- and under-diagnose.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Localize
- LH/FSH (testes vs pituitary)
- Catch upstream
- Prolactin (prolactinoma)
- Free fraction
- SHBG + calculated free T
- Reversible
- Iron studies, metabolic panel
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Reading Your Full Hormone Panel. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What can go wrong. We have not written the risk line for this one. Read the safety section below rather than treating its absence as reassurance.
- Where we land. We have not taken a position on this yet.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.